Verrecchia, Elena
 Distribuzione geografica
Continente #
EU - Europa 1.924
NA - Nord America 1.659
AS - Asia 1.433
SA - Sud America 310
AF - Africa 29
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 3
Totale 5.363
Nazione #
US - Stati Uniti d'America 1.604
DE - Germania 839
SG - Singapore 782
CN - Cina 323
SE - Svezia 279
BR - Brasile 265
IT - Italia 217
FR - Francia 160
GB - Regno Unito 94
UA - Ucraina 78
VN - Vietnam 78
IE - Irlanda 73
ID - Indonesia 48
FI - Finlandia 46
RU - Federazione Russa 41
IN - India 34
CA - Canada 30
TR - Turchia 27
HK - Hong Kong 22
PL - Polonia 21
AR - Argentina 18
BD - Bangladesh 18
AT - Austria 17
MX - Messico 16
BE - Belgio 15
IQ - Iraq 14
SA - Arabia Saudita 11
EC - Ecuador 10
KR - Corea 10
ES - Italia 9
UZ - Uzbekistan 9
JP - Giappone 8
ZA - Sudafrica 8
IR - Iran 7
LT - Lituania 7
NL - Olanda 7
LB - Libano 5
MA - Marocco 5
PH - Filippine 5
RO - Romania 5
AM - Armenia 4
EG - Egitto 4
EU - Europa 4
IL - Israele 4
KG - Kirghizistan 4
PY - Paraguay 4
VE - Venezuela 4
AZ - Azerbaigian 3
BG - Bulgaria 3
CI - Costa d'Avorio 3
DK - Danimarca 3
DZ - Algeria 3
JO - Giordania 3
PE - Perù 3
AU - Australia 2
BH - Bahrain 2
BO - Bolivia 2
CL - Cile 2
CZ - Repubblica Ceca 2
GR - Grecia 2
JM - Giamaica 2
KE - Kenya 2
LU - Lussemburgo 2
NP - Nepal 2
PK - Pakistan 2
PR - Porto Rico 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BY - Bielorussia 1
CH - Svizzera 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
ME - Montenegro 1
MY - Malesia 1
NI - Nicaragua 1
PA - Panama 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TV - Tuvalu 1
TW - Taiwan 1
UY - Uruguay 1
Totale 5.363
Città #
Singapore 435
Chandler 345
Ashburn 179
Beijing 65
Marseille 63
Dublin 60
New York 60
Los Angeles 55
San Mateo 54
Ann Arbor 47
Nürnberg 44
Hefei 43
Jakarta 43
Rome 37
Jacksonville 34
Munich 34
Wilmington 32
Moscow 31
Boston 29
Milan 29
Redmond 29
Ho Chi Minh City 27
Nanjing 27
Cattolica 26
Princeton 25
Houston 24
São Paulo 22
Hong Kong 21
Dearborn 18
Frankfurt am Main 18
Brussels 15
Izmir 15
Hanoi 14
Montreal 14
Buffalo 13
Dallas 13
Turku 13
Chicago 12
Helsinki 12
Kent 12
Kraków 12
Nuremberg 11
Boardman 10
Hyderabad 10
Mexico City 10
Woodbridge 10
Fairfield 9
Hangzhou 9
London 9
The Dalles 9
Bremen 8
Hebei 8
Lawrence 8
Nanchang 8
Phoenix 8
Porto Alegre 8
Rio de Janeiro 8
Roubaix 8
Santa Clara 8
Seoul 8
Stockholm 8
Tashkent 8
Haiphong 7
Redwood City 7
Shenyang 7
Tianjin 7
Tokyo 7
Augusta 6
Changsha 6
Denver 6
Düsseldorf 6
Vienna 6
Ankara 5
Brooklyn 5
Campinas 5
Cisterna Di Latina 5
Dhaka 5
Guayaquil 5
Jeddah 5
Lappeenranta 5
Manchester 5
Menlo Park 5
Orem 5
Portsmouth 5
Riyadh 5
San Francisco 5
Seattle 5
Shanghai 5
Wroclaw 5
Andover 4
Baghdad 4
Belo Horizonte 4
Betim 4
Brasília 4
Castiglione del Lago 4
Charlotte 4
Chennai 4
Curitiba 4
Da Nang 4
Detroit 4
Totale 2.478
Nome #
Clinical features of familial Mediterranean fever: an Italian overview. 353
Gastrointestinal amyloidosis: a case of chronic diarrhoea. 325
Atypical sarcoidosis: case reports and review of the literature. 189
Familial Mediterranean Fever: a review for clinical management. 176
IL-1β biological treatment of familial Mediterranean fever. 169
Female reproductive dysfunction in familial Mediterranean fever patients with and without colchicine treatment 165
Febbre ed ipertermia 162
Epidemiology of FMF Worldwide 158
Cyclosporine A: good response for patients affected by autoimmune disorders and HCV infection? 156
The impact of fever/hyperthermia in the diagnosis of Fabry: A retrospective analysis. 155
The impact of fever/hyperthermia in the diagnosis of Fabry: A retrospective analysis 147
Right Ventricular Hypertrophy, Systolic Function, and Disease Severity in Anderson-Fabry Disease: An Echocardiographic Study 142
IL-1beta Biological Treatment of Familial Mediterranean Fever 133
Rare missense variants in the ALPK1 gene may predispose to periodic fever, aphthous stomatitis, pharyngitis and adenitis (PFAPA) syndrome. 131
Effectiveness of colchicine therapy in 4 cases of retroperitoneal fibrosis associated with autoinflammatory diseases 125
Diagnostic criteria for adult-onset Periodic Fever, Aphthous stomatitis, Pharyngitis, and cervical Adenitis (PFAPA) syndrome 111
Right ventricular strain in Anderson-Fabry disease 111
Transitional care management in patients with auto-inflammatory diseases: experience of cooperation of a paediatric and adult centre 111
Caregivers’ and Physicians’ Perspectives on Alpha-Mannosidosis: A Report from Italy 110
Gain-of-function mutations in ALPK1 cause an NF-κB-mediated autoinflammatory disease: functional assessment, clinical phenotyping and disease course of patients with ROSAH syndrome 109
Current advances in the understanding and treatment of mevalonate kinase deficiency 105
Switch from anakinra to canakinumab in a severe case of CINCA syndrome 104
Children and adults with PFAPA syndrome: similarities and divergences in a real-life clinical setting 103
The AutoInflammatory Diseases Alliance Registry of monogenic autoinflammatory diseases 99
An uplifted destiny for mucopolysaccharidosis type I with heart involvement 95
Resolution of femoral metaphyseal dysplasia in CINCA syndrome after long-term treatment with interleukin-1 blockade 94
Fabry disease in internal medicine: the role of fever and hyperthermia in diagnosis 93
Risk for cancer development in familial Mediterranean fever and associated predisposing factors: an ambidirectional cohort study from the international AIDA Network registries 91
Efficacy and safety of anakinra in radiation-induced acute pericarditis: a case report 90
Small Intestinal Bacterial Overgrowth Affects the Responsiveness to Colchicine in Familial Mediterranean Fever 90
Biotechnological agents for patients with tumor necrosis factor receptor associated periodic syndrome - Therapeutic outcome and predictors of response: real-life data from the AIDA Network 86
Long-term treatment with anakinra and canakinumab resolves patellar subchondral erosion in neonatal-onset multisystem inflammatory disease 85
Survey about the quality of life of italian patients with Fabry disease 83
Identification by Exome Sequencing of Predisposing Variants in Familial Cases of Autoinflammatory Recurrent Fevers 76
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real life clinical practice: a nationwide multicenter retrospective observational study 75
Drug survival of anakinra and canakinumab in monogenic autoinflammatory diseases: observational study from the International AIDA Registry 75
Sarcoidosis and Cancer: The Role of the Granulomatous Reaction as a Double-Edged Sword 73
An uplifted destiny for mucopolysaccharidosis type I with heart valve involvement 71
Development and implementation of the AIDA International Registry for patients with Periodic Fever, Aphthous stomatitis, Pharyngitis, and cervical Adenitis syndrome 69
NLRP12 gene mutations and auto-inflammatory diseases: Ever-changing evidence 68
Anderson-Fabry's Disease: A Rare but Treatable Case of Fever of Unknown Origin 63
Incessant Pericarditis Successfully Treated With Anakinra in a Patient on Active Treatment for Mediastinal Lymphoma 63
Cutibacterium acnes in the aetiopathogenesis of sarcoidosis: current insights and future study directions 55
REPORT ON A COHORT OF ITALIAN PATIENTS AFFECTED BY FAMILIAL MEDITERRANEAN FEVER: PHENOTYPE AND GENOTYPE CHARACTERIZATION, WITH A SPECIFIC FOCUS ON ASSOCIATED IMMUNE MEDIATED DISEASE 54
Predictors of proteinuria, amyloidosis and kidney failure in familial Mediterranean fever: data from the International AIDA Network Registry. 53
Interleukin-1 Blockers in Recurrent and Acute Pericarditis: State of the Art and Future Directions 51
LONG-TERM EFFICACY OF ANTI IL1 INHIBITION SEVERE JOINT INVOLVEMENT IN AN FMF PATIENT 41
The impact of fever and dystermia in Fabry's disease diagnosis: a retrospective analysis 31
REPORT ON A COHORT OF ITALIAN PATIENTS AFFECTED BY FAMILIAL MEDITERRANEAN FEVER: PHENOTYPE AND GENOTYPE CHARACTERIZATION, WITH A SPECIFIC FOCUS ON ASSOCIATED IMMUNE MEDIATED DISEASE 23
LONG-TERM EFFICACY OF ANTI IL1 INHIBITION SEVERE JOINT INVOLVEMENT IN AN FMF PATIENT 23
Totale 5.420
Categoria #
all - tutte 21.908
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.908


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202190 0 0 0 0 0 9 16 7 23 3 31 1
2021/2022412 27 21 6 41 41 8 8 64 11 21 76 88
2022/2023860 117 117 65 131 54 109 71 66 95 9 19 7
2023/2024421 20 116 7 47 11 67 16 5 2 18 61 51
2024/2025853 19 23 52 25 66 24 24 43 140 89 172 176
2025/20261.473 309 106 175 326 493 64 0 0 0 0 0 0
Totale 5.420